Evidence map›Paper›PMID 24886428›Full record

ArticleBMC immunology2014

A PKC-SHP1 signaling axis desensitizes Fcγ receptor signaling by reducing the tyrosine phosphorylation of CBL and regulates FcγR mediated phagocytosis.

Shweta Joshi, Alok Ranjan Singh, Muamera Zulcic, Donald L Durden

Abstract read
In one paragraph

Article in BMC immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Immunoreceptors on neutrophils.Seminars in immunology · 2016
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shweta Joshi
Alok Ranjan Singh
Muamera Zulcic
Donald L DurdenUCSD Department of Pediatrics, Moores UCSD Cancer Center, University of California School of Medicine, San Diego, CA 92093, USA. ddurden@ucsd.edu.

Funding

Vascular targeted pan PI-3 kinase inhibitor prodrug, SF1126 for glioma therapyR01CA094233 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DURDEN, DONALD · 2002 to 2012
$2.4M
Vascular targeted pan PI-3kinase inhibitor prodrug, SF1126 for glioma therapy.R56CA094233 · NCI · EMORY UNIVERSITY · PI DURDEN, DONALD · 2008 to 2008
$224k
NCI NIH HHS CA94233NHLBI NIH HHS HL091395
6 · The paper itself

Abstract

backgroundFcγ receptors mediate important biological signals in myeloid cells including the ingestion of microorganisms through a process of phagocytosis. It is well-known that Fcγ receptor (FcγR) crosslinking induces the tyrosine phosphorylation of CBL which is associated with FcγR mediated phagocytosis, however how signaling molecules coordinate to desensitize these receptors is unclear. An investigation of the mechanisms involved in receptor desensitization will provide new insight into potential mechanisms by which signaling molecules may downregulate tyrosine phosphorylation dependent signaling events to terminate important signaling processes.

resultsUsing the U937IF cell line, we observed that FcγR1 crosslinking induces the tyrosine phosphorylation of CBL, which is maximal at 5 min. followed by a kinetic pattern of dephosphorylation. An investigation of the mechanisms involved in receptor desensitization revealed that pretreatment of U937IF or J774 cells with PMA followed by Fcγ receptor crosslinking results in the reduced tyrosine phosphorylation of CBL and the abrogation of downstream signals, such as CBL-CRKL binding, Rac-GTP activation and the phagocytic response. Pretreatment of J774 cells with GF109203X, a PKC inhibitor was observed to block dephosphorylation of CBL and rescued the phagocytic response. We demonstrate that the PKC induced desensitization of FcγR/ phagocytosis is associated with the inactivation of Rac-GTP, which is deactivated in a hematopoietic specific phosphatase SHP1 dependent manner following ITAM stimulation. The effect of PKC on FcγR signaling is augmented by the transfection of catalytically active SHP1 and not by the transfection of catalytic dead SHP1 (C124S).

conclusionsOur results suggest a functional model by which PKC interacts with SHP1 to affect the phosphorylation state of CBL, the activation state of Rac and the negative regulation of ITAM signaling i.e. Fcγ receptor mediated phagocytosis. These findings suggest a mechanism for Fcγ receptor desensitization by which a serine-threonine kinase e.g. PKC downregulates tyrosine phosphorylation dependent signaling events via the reduced tyrosine phosphorylation of the complex adapter protein, CBL.

Indexed as

Signal TransductionAdaptor Proteins, Signal TransducingAnimalsCell LineEnzyme ActivationErythrocytesHumansImmunoglobulin GModels, BiologicalNuclear ProteinsPhagocytosisPhosphorylationProtein BindingProtein Kinase CProtein Tyrosine Phosphatase, Non-Receptor Type 6Proto-Oncogene Proteins c-cblAdaptor Proteins, Signal TransducingCRKL proteinFCGR1A protein, humanImmunoglobulin GNuclear ProteinsProtein Kinase CProtein Tyrosine Phosphatase, Non-Receptor Type 6Proto-Oncogene Proteins c-cblrac GTP-Binding ProteinsReceptors, IgG

Identifiers

PMID24886428
PMCPMC4017086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.